Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
75.1K
-
Shares change
-
+45.2K
-
Total reported value, excl. options
-
$307K
-
Value change
-
+$185K
-
Number of buys
-
1
-
Price
-
$4.09
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q4 2023
2 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q4 2023.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.1K shares
of 127M outstanding shares and own 0.06% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (13.4M shares), Soleus Capital Management, L.P. (8.96M shares), VANGUARD GROUP INC (5.36M shares), BlackRock Inc. (5.2M shares), ACADIAN ASSET MANAGEMENT LLC (2.53M shares), DEUTSCHE BANK AG\ (2.51M shares), GEODE CAPITAL MANAGEMENT, LLC (1.7M shares), STATE STREET CORP (1.4M shares), DIMENSIONAL FUND ADVISORS LP (1.39M shares), and AQR CAPITAL MANAGEMENT LLC (1.19M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.